VIA

Virtus Investment Advisers Portfolio holdings

AUM $296M
This Quarter Return
+9.26%
1 Year Return
+31.42%
3 Year Return
+126.24%
5 Year Return
–
10 Year Return
–
AUM
$296M
AUM Growth
-$72M
Cap. Flow
-$86.7M
Cap. Flow %
-29.31%
Top 10 Hldgs %
6.88%
Holding
512
New
39
Increased
197
Reduced
202
Closed
70

Top Buys

1
CEG icon
Constellation Energy
CEG
$2.01M
2
DASH icon
DoorDash
DASH
$1.82M
3
VEEV icon
Veeva Systems
VEEV
$1.75M
4
CSCO icon
Cisco
CSCO
$1.7M
5
STT icon
State Street
STT
$1.69M

Top Sells

1
VABS icon
Virtus Newfleet ABS/MBS ETF
VABS
$32.2M
2
VSHY icon
Virtus Newfleet Short Duration High Yield Bond ETF
VSHY
$24.6M
3
SEIX icon
Virtus SEIX Senior Loan ETF
SEIX
$19M
4
SMC
Summit Midstream Corporation
SMC
$3.67M
5
JNK icon
SPDR Bloomberg High Yield Bond ETF
JNK
$2.09M

Sector Composition

1 Financials 33.24%
2 Healthcare 17.43%
3 Technology 12.41%
4 Industrials 9.1%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MAZE
401
Maze Therapeutics, Inc. Common Stock
MAZE
$666M
$85.2K 0.03%
+6,940
New +$85.2K
BHVN icon
402
Biohaven
BHVN
$1.71B
$85.1K 0.03%
6,032
+1,949
+48% +$27.5K
JANX icon
403
Janux Therapeutics
JANX
$1.38B
$85K 0.03%
3,679
+1,011
+38% +$23.4K
WVE icon
404
Wave Life Sciences
WVE
$1.27B
$84.9K 0.03%
13,060
+1,210
+10% +$7.87K
RVMD icon
405
Revolution Medicines
RVMD
$7.43B
$84.1K 0.03%
2,287
-1,365
-37% -$50.2K
CRNX icon
406
Crinetics Pharmaceuticals
CRNX
$3.26B
$84.1K 0.03%
2,923
-30
-1% -$863
VRDN icon
407
Viridian Therapeutics
VRDN
$1.59B
$83.9K 0.03%
6,001
-3,128
-34% -$43.7K
MNMD icon
408
MindMed
MNMD
$689M
$83.6K 0.03%
12,881
-10,507
-45% -$68.2K
ANNX icon
409
Annexon
ANNX
$225M
$83.3K 0.03%
34,698
-1,701
-5% -$4.08K
TECX
410
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
$83.3K 0.03%
4,190
+649
+18% +$12.9K
RNA icon
411
Avidity Biosciences
RNA
$6.12B
$83.1K 0.03%
2,926
-1,934
-40% -$54.9K
SNDX icon
412
Syndax Pharmaceuticals
SNDX
$1.39B
$82.5K 0.03%
8,813
-3,379
-28% -$31.6K
IMTX icon
413
Immatics
IMTX
$662M
$82.4K 0.03%
15,315
-6,838
-31% -$36.8K
QURE icon
414
uniQure
QURE
$954M
$82K 0.03%
5,881
-5,025
-46% -$70K
TSHA icon
415
Taysha Gene Therapies
TSHA
$791M
$82K 0.03%
35,484
-37,473
-51% -$86.6K
RCUS icon
416
Arcus Biosciences
RCUS
$1.24B
$81.9K 0.03%
10,057
+485
+5% +$3.95K
KURA icon
417
Kura Oncology
KURA
$732M
$81.5K 0.03%
14,119
-2,823
-17% -$16.3K
KALV icon
418
KalVista Pharmaceuticals
KALV
$713M
$81.2K 0.03%
+7,184
New +$81.2K
ABUS icon
419
Arbutus Biopharma
ABUS
$753M
$81.2K 0.03%
26,266
-19,848
-43% -$61.3K
LQDA icon
420
Liquidia Corp
LQDA
$2.52B
$81.1K 0.03%
6,507
-8,403
-56% -$105K
NAMS icon
421
NewAmsterdam Pharma
NAMS
$2.8B
$81K 0.03%
4,471
-2,072
-32% -$37.5K
TRDA icon
422
Entrada Therapeutics
TRDA
$202M
$80.5K 0.03%
11,979
+2,914
+32% +$19.6K
EWTX icon
423
Edgewise Therapeutics
EWTX
$1.54B
$79.9K 0.03%
6,098
+269
+5% +$3.53K
SYRE icon
424
Spyre Therapeutics
SYRE
$1.02B
$79.5K 0.03%
5,310
-1,551
-23% -$23.2K
CGEM icon
425
Cullinan Oncology
CGEM
$456M
$79.1K 0.03%
10,506
-2,949
-22% -$22.2K
15 16
17
18 19